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 27 
'key messages' 28 
• Using the data from the National Audit of Cancer Diagnosis in Primary Care, we examined how 29 
different symptoms and patient demographics predict variations in time to brain tumour diagnosis.  30 
• Our results indicate overall a relatively short time to diagnosis, but with the potential for avoidable 31 
delay for patients presenting with headache only or with memory complaints.  32 
• General practitioners would benefit from better methods to differentiate which patients with 33 
headaches or with memory complaints may benefit from rapid referral. 34 
 35 
36 
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Background: Brain tumours often present with varied, non-specific features with other diagnoses usually 37 
being more likely. 38 
Objective: To examine how different symptoms and patient demographics predict variations in time to 39 
brain tumour diagnosis. 40 
Methods: Secondary analysis of brain tumour cases from National Audit of Cancer Diagnosis in Primary 41 
Care. We grouped neurological symptoms into 6 domains (headache, behavioural/cognitive change, focal 42 
neurology, “fits, faints, or falls”, non-specific neurological, and other/non-specific) and calculated times for   43 
patient presentation, general practitioner referral, specialist consultation and total pathway interval. We 44 
calculated odds ratios (ORs) for symptom domains comparing the slowest to other quartiles. 45 
Results: Data were available for 226 cases. Median (inter-quartile range) time for the total pathway interval 46 
was 24 days (7-65 days). The most common presentation was focal neurology (33.2%) followed by “fits, 47 
faints or falls” and headache (both 20.8%). Headache only (OR 4.11, 95% CI 1.10, 15.5) and memory 48 
complaints (4.82, 95% CI 1.15, 20.1) were associated with slower total pathway compared to “fits, faints or 49 
falls”. General practitioners were more likely to consider that there had been avoidable delays in referring 50 
patients with headache only (OR 4.17, 95% CI 1.14, 15.3).  51 
Conclusion: Patients presenting to primary care with headache only, or with memory complaints remain 52 
problematic with potentially avoidable delays in referral leading to a longer patient pathway. This may or 53 
may not impact on the efficacy and morbidity of therapies. Additional aids are required to help doctors 54 
differentiate when to refer headaches and memory complaints urgently for a specialist opinion.  55 
 56 
Key words: Brain tumour, symptoms, delay in accessing care, National Audit of Cancer Diagnosis in 57 
Primary Care, diagnosis 58 
59 
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Introduction 60 
The incidence of brain tumours is low; age-adjusted incidence rates for all gliomas range from 4.7 to 5.7 per 61 
100,000 persons.
1
 This means that the diagnosis of brain tumour is very rare in primary care populations. 62 
While the diagnosis of cancer is usually made in secondary care, most patients will have seen their General 63 
Practitioner (GP) prior to a diagnosis.
2-4
 Further, patients can present with a wide range of different 64 
symptoms which may be common (e.g. headache), non-threatening, or may be thought of as part of a 65 
normal ageing process (e.g. memory loss). The non-specificity of these symptoms creates a diagnostic 66 
challenge for all clinical staff. Current guidelines in the United Kingdom recommend that all patients with 67 
suspected CNS tumour must be seen by a specialist within 2 weeks of referral by their general practitioner 68 
(GP) but despite the introduction of this guideline in 2005, there appears to have been little improvement in 69 
the diagnostic interval
5
 (the time from first presentation with symptoms to diagnosis) over the last decade.
6
 70 
Indeed, most recent figures show only 1% of cases with suspected brain tumour are diagnosed through the 71 
“suspected cancer” two-week wait process, while 17% are GP referrals through usual pathways, and 58% 72 
are diagnosed after an accident and emergency attendance.
7
 73 
 74 
Several studies have examined case series of patients with brain tumours and have quantified the frequency 75 
of the most common presenting symptoms;
8-9
 in some cases deriving predictive values by comparing this to 76 
age-sex matched control patients in primary care.
10-15
 A systematic review
16
 found that all symptoms had in 77 
general low positive predictive values for brain tumours, apart from new-onset epilepsy. Few studies have 78 
investigated how symptoms may influence the time to diagnosis. The National Audit of Cancer Diagnosis 79 
in Primary Care (NACDPC) has previously found that around a third (35.2%) of patients with brain 80 
tumours took 15 days or more to present to their general practitioner (GP)
17
 and 21.4% of cases required 81 
three or more consultations before referral compared to 17.9% for all cancers or as little as 2.9% for breast 82 
cancer patients.
18
   83 
 84 
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This study examines whether different clinical presentations are associated with variations in the patient 85 
pathway to diagnosis and where future interventions could be best targeted to reduce diagnostic delay and 86 
possibly improve patient prognosis.  87 
 88 
Material and Methods 89 
Data 90 
We analyzed data from the (English) National Audit of Cancer Diagnosis in Primary Care (NACDPC) 91 
(2009-2010). Data were collected from 18,879 patients by 1,170 practices (~14% of all practices in 92 
England) in 20 cancer networks using an audit template and information from their practice clinical records 93 
and hospital correspondence. Any screen-detected or incidental cancers were excluded from the audit. 94 
Patient demographics and the information related to the assessment process in primary care were collected 95 
(for full details concerning the NACDPC methods see the report by Royal College of General 96 
Practitioners).
19
 97 
 98 
Outcomes 99 
Only patients with a confirmed diagnosis of brain tumour (no details on specific pathology were available) 100 
were selected for this analysis. We examined time to four specific outcomes to try and understand the 101 
clinical pathway from symptom onset to specialist consultation (see figure 1 for visual representation). 102 
These were: 1) Time from patient recognition of symptoms until first GP consultation (“patient interval”). 103 
2) Time from first GP consultation until referral to specialist (“primary care interval”). 3) Time from referral 104 
until specialist attendance (“specialist interval”). 4) Total time from patient recognition of symptoms until 105 
first specialist visit (sum of 1 and 2 and 3 above) (“pathway interval”). 106 
 107 
In addition, we looked at three other related outcomes that may indicate a sub-optimal referral interval: (a) if 108 
the patient attended primary care 3 or more times before referral and (b) the GP’s response to the following 109 
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questions (i) “Would rapid access to investigations have altered your management of this case?” and (ii) 110 
Were there any avoidable delays to this patient's journey? In this latter case, GPs could respond No, Yes or 111 
Unsure. Due to small numbers, we combined Unsure and NO to create a binary outcome variable (Yes 112 
versus unsure/no). These last two variables are retrospective in nature. 113 
 114 
Clinical symptoms 115 
The information on patient records was collected by general practitioners or primary care professionals. We 116 
grouped individual symptoms into 6 domains based on categorizations of previous papers and the region of 117 
brain likely to be causing the symptom (intra-cerebral damage - focal neurology), intra-cerebral damage - 118 
cognitive / behavioural); intra-cerebral excitation (seizure); intracranial extra-cerebral damage - cranial 119 
nerve); raised pressure (headache), and “non specific” based on specialist opinions (PB, KZ, RG) (see 120 
supplementary table 1). We created the following domains; 1) headache, 2) behavioural/cognitive change, 3) 121 
focal neurology including stroke 4) episodic attacks – “fits, faints and falls” 5) non-specific neurological, and 122 
6) other/non-specific features. Headache and behavioural/ cognitive change were further divided into 2 123 
subgroups: headache was divided into headache only and headache plus additional features recorded, whilst 124 
behavioural/cognitive change was divided into confusion and memory only sub-groups. If more than one 125 
symptom was recorded (other than for the headache plus group), we chose what we considered to be the 126 
main symptom for classification purposes. 127 
 128 
Other covariates 129 
We also examined the following covariates: gender, age group (less than 60, 60 to 70, over 70 years), 130 
ethnicity (white British vs. other), whether the patient had problems in communication, was housebound, 131 
whether the GP ordered investigations before referral, type of referral, where patients first presented, and 132 
which specialist was chosen for the referral.  133 
 134 
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Statistical Analysis 135 
We calculated the median (inter-quartile range) time to diagnosis (in days) according to patient, referral, 136 
specialist and pathway intervals by symptom domains, and other factors. As the time data were highly 137 
skewed, we derived a binary outcome variable indicating slower time interval by deriving quartiles and 138 
comparing patients in the slowest versus the other three quartiles. We compared each symptom domain 139 
relative to fits, faints and falls (baseline group) as this domain was associated with the shortest pathway 140 
interval.  141 
 142 
We calculated odds ratios (ORs), 95% confidence intervals (CI) and p-values using multivariable logistic 143 
regression and treating symptom domain as a dummy variable. We calculated crude and multivariable odds 144 
ratios, adjusting for age group, sex, and ethnicity as these co-variates are potential confounders as they may determine 145 
how symptoms are perceived by the patients and present to the general practitioner as well as influencing time to see 146 
general practitioner and referral. Because of missing data for the time intervals, we undertook multiple 147 
imputation using chained equations for our binary outcomes so that we could use all the cases in our logistic 148 
regression model. This analysis is potentially less biased due to missing data. The imputation model 149 
included all variables from our analysis model as well as covariates shown in table 1. We used 20 cycles for 150 
the chained equations and derived 10 imputed datasets, which were then combined using Rubin’s rules to 151 
derive the appropriate odds ratios, 95% confidence intervals and p-values using the mi estimate command 152 
in Stata. The multivariable odds ratios are based on the imputed dataset to maximise statistical power, given 153 
the relatively small sample size.  154 
 155 
Results 156 
There were 226 patients (96.6%) with information on presenting symptoms from 234 brain tumour cases. 157 
The age distribution was bimodal (younger and older) with roughly equal numbers of men and women 158 
(Table 1) The most common symptom domain was focal neurology including stroke (33.2%), followed by 159 
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episodic attacks – “fits, faints or falls” (20.8%), and headache (20.8%). About 30% of cases had 160 
experienced three or more consultations prior to referral. In around a third of cases GPs considered, or were 161 
not sure if, there had been avoidable delays. In around 20% the GPs felt that rapid access to investigations 162 
would have been helpful.  163 
 164 
The median (inter-quartile range) of the pathway interval was 24 days (7-65 days) (Table 2). Younger 165 
patients (< 60 years) had longer delays on the pathway. There were marked variations in the pathway 166 
interval by symptom domain. The shortest time was seen for episodic attacks – “fits, faints or falls” (10 167 
days) whilst the longest interval was seen for memory loss (62 days). Patients who had investigations 168 
before referral to specialist care had a longer pathway interval.    169 
 170 
Table 3 shows the odds ratios and 95% confidence intervals for the longest quartile of time intervals for 171 
each stage of the patient pathway. Compared to “fits, faints or falls”, headache and the non-specific 172 
neurological group showed a significantly elevated odds ratio for the referral (OR 6.47, 95% CI 1.22, 34.3 173 
and OR 11.9, 95% CI 1.82, 77.8, respectively). When we looked at the sub-groups, headache only (i.e. 174 
headache without any other reported features), and memory only, they showed larger odds ratios for the 175 
total pathway interval (OR 4.11, 95% CI 1.10, 15.5 and OR 4.82, 95% CI 1.15, 20.1, respectively), which 176 
was mainly driven by the slower primary care interval (OR 11.8, 95% CI 1.88, 73.9 and OR 10.9, 95% CI 177 
1.79, 66.1, respectively). GP diagnostic investigations before referral were also associated with slower 178 
referral and slower overall pathways. Unsurprisingly, patients who were referred routinely had longer 179 
primary care and specialist delays, with referral to A&E having shorter patient, specialist and pathway 180 
interval. The results of non-imputed model are shown in supplementary table 2. 181 
 182 
Both headache and behavioural/cognitive changes and non-specific symptoms were associated with at least 183 
3 or more presentations before referral (table 4) and this was most marked for headache only (OR 7.92, 184 
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95% CI 1.80, 34.8), and memory complaints (OR 6.09, 95% CI 1.30, 28.6). GPs considered that faster 185 
access to investigations would have helped for both headaches and focal neurology symptoms. GPs 186 
retrospectively reported that there had been avoidable delays for patients presenting with headache only in 187 
the patient journey (OR 3.64, 95% CI 0.83, 15.9) but this was consistent with chance.  188 
  189 
Discussion 190 
This is the first study to examine how different symptoms affect the patient pathway interval, using a 191 
representative sample of brain tumour cases from the NACDPC study. We find marked variability in time 192 
from symptom onset to first specialist attendance for patients with brain tumours, depending on their 193 
symptoms. Overall, the median time from symptom presentation until being seen by a specialist is less than 194 
4 weeks. Patients presenting with headaches, behavioural/cognitive changes or other/non-specific 195 
symptoms attended their GP more frequently before referral; headache only and memory loss are 196 
associated with a much slower patient pathway mainly due to delays in referral to a specialist (secondary 197 
care). In addition, younger patients under the age of 60 years and patients over the age 69 also tend to 198 
experience delays in referral and specialist consultation.  199 
 200 
Most previous studies of the diagnostic pathway have focused on very specific tumour types, e.g. vestibular 201 
schwannoma,
20
 intradural spinal cord tumours,
21
 pituitary adenomas,
21
 acoustic neuromas,
22
 central nervous 202 
lymphomas,
23
 or intracranial germ cell tumours
24
 (e.g.
23,25,26
). Similarly, non-specific or more subtle features 203 
such as personality changes were associated with delayed referral in a case series of 58 patients with 204 
primary central nervous system lymphoma.
23,27
 Retrospective interviews with patients and relatives can 205 
elicit prior histories of more subtle problems such as cognitive or personality change, though these 206 
symptoms may be ignored by the patient.
9
 207 
 208 
The positive predictive value of headache for adult patients with brain tumours is low (0.09% overall but 209 
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0.12% in 60-69 year olds) as compared to new onset seizure (1.2%).
16
 Since headache is a common 210 
complaint, it is difficult for GPs and other doctors to differentiate less serious causes of headache from 211 
headaches secondary to a brain tumour. Headaches associated with brain tumours are frequently of “tension” 212 
type or mimic migraine
8
 and the best clues are increasing frequency and severity, and headache features (e.g. 213 
worsening with cough or bending, nocturnal headaches or headaches on wakening). The development of 214 
additional symptoms e.g. focal neurology or signs (papilloedema) will strongly support the diagnosis. This 215 
underlines the importance that GPs search for the presence of additional symptoms, such as 216 
behavioural/cognitive changes if uncertain as to whether a patient with headache requires investigations or 217 
specialist referral. The use of simple cognitive screening tests, such as semantic verbal fluency (SVF), may 218 
help. This requires assessment of how many animals the patient can name in one minute and has been 219 
previously demonstrated to be worse in brain tumour patients whose initial presenting symptom was 220 
headache/headache “plus”.
28,29
  221 
 222 
Strengths and limitations 223 
The study has good generalizability to other high income healthcare settings, as cases were identified 224 
consecutively from primary care, without any selection by specialist units. Most studies do not 225 
prospectively collect data on patient delay, so cannot untangle the patient pathway into all its constituent 226 
components. However, we were forced to group various symptoms into domains to achieve sufficient 227 
power due to the sample size. In addition, the reporting of potentially avoidable delays and whether further 228 
investigation would have helped was done retrospectively by the GPs, so may have been biased by the 229 
actual patient outcomes. For some non-acute features, such as behavioural change, patients may have 230 
incorrectly reported the date of symptom onset. Some patients who had a first ever presentation directly to 231 
accident and emergency departments and were hospitalised would have not been included in this dataset, 232 
although this is not directly relevant to the issue of improving diagnostic delay in elective primary care. We 233 
included headaches associated with ‘nausea’ and ‘vomiting’ (N&V) under the headache plus group given 234 
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the lack of qualifying information in the data available. Ideally though there would be a distinction between 235 
N&V seen in common conditions such as migraine, and ‘atypical’ or ‘red flag’ N&V (such as N&V 236 
confined to early mornings, or on bending down) which alerts the GP to the possibility of more serious 237 
pathology – such as a brain tumour. We could not look at how presentation and delay was associated with 238 
type of brain tumour as we did not have data on the specific pathology, size and location. This would be of 239 
interest as it would also be associated with management and prognosis.  240 
 241 
Interestingly, GPs considered that more rapid access to investigations, such as neuroimaging, would have 242 
helped, particularly for less specific symptoms such as headache.
30,31
 This important question needs to be 243 
looked at in terms of cost-effectiveness given the potential large number of patients that will turn out to have 244 
a normal scan. Current National Institute for Health and Care Excellence (NICE) guidance states “Consider 245 
an urgent direct access MRI scan of the brain (or CT scan if MRI is contraindicated) (to be performed 246 
within 2 weeks) to assess for brain or central nervous system cancer in adults with progressive, sub‑acute 247 
loss of central neurological function.”
32 
Patients with only headache or simple memory loss would not in 248 
themselves be considered to meet these criteria. In addition, there is an implicit assumption that the 249 
reduction in the diagnostic interval for patients presenting with headaches and memory loss would translate 250 
into better clinical outcomes, which may or may not be true. Future work should examine whether 251 
geographical areas with rapid access to neuroimaging have reduced delay in time to diagnosis and whether 252 
this translates to differences in patient management, morbidity and survival. 253 
 254 
Conclusions 255 
Whilst many patients with brain tumours are diagnosed rapidly, GPs and other doctors currently face a 256 
diagnostic challenge when deciding whether to refer patients with headaches and memory complaints. 257 
Future work needs to identify whether any additional features or other simple inexpensive tests could be 258 
administered in primary care that could help reduce the time to diagnosis in these patients.  259 
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Figure legend 286 
Figure 1. The pathway and time to diagnosis for patients with brain tumour  287 
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Table 1. Socio-demographic characteristics of patients of brain tumour, n=226 
Variable Freq. %     Freq. % 
Age group    Investigation before referral   
<60 82 36.3  No 142 62.8 
60-69 55 24.3  Yes 70 31.0 
≥70 84 37.2  Unknown 14 6.2 
Unknown 5 2.2  
   
    Which specialist to be referred  
Sex    Neurology 55 24.3 
Female 105 46.5  Accident & Emergency 18 8.0 
Male 121 53.5  Medicine & Geriatrics 50 22.1 
    Ophthalmology 17 7.5 
Ethnicity    Neurosurgery 19 8.4 
White british 177 78.3  Paediatrics 11 4.9 
Other 29 12.8  Stroke 9 4.0 
Unknown 20 8.9  Miscellaneous 17 7.5 
   
 Unknown 30 13.3 
Housebound   
No 187 82.7  Type of referral   
Yes 27 12.0  Emergency 90 39.82 
Unknown 12 5.3  Not referred by practice 34 15.04 
 2 week/private 41 18.14 
Problems in communication   Routine 39 17.26 
No 187 82.7  Unknown 22 9.73 
Dementia 4 1.8  
   Language barrier 8 3.5  Attended 3+ before referral  
Leaning difficulty 2 0.9  No 119 62.7 
Mental Health 2 0.9  Yes 76 33.6 
Poor vision 1 0.4  Unknown 31 13.7 
Speech impediment 11 4.9  
Unknown 11 4.9  Rapid access investigations 
  
 No 157 69.5 
Symptoms  Yes 46 20.4 
Headache 47 20.8  Unknown 23 10.1 
     Headache only 16 
 
 
        Headache plus 31 
 
 Avoidable delays in patient journey 
Behavioural/cognitive  28 12.4  No 153 67.7 
     Confusion 14 
 
 Yes 68 30.1 
     Memory 14 
 
 Unknown 5 2.2 
Focal neurology 75 33.2 
 
   Fits, faints or falls 47 20.8 
 
   Non-specific neuological 11 4.9 
 
Other/non-specific 18 8.0         
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Table 2. Median and interquartile range of time to diagnosis (days) by socio-demographic characteristics of patients with a brain tumour 
Time to diagnosis 
 
Patient interval
*1
 
 
Primary care interval
*2
 
 
Specialist interval
*3
 
 
Pathway interval
*4
 
Variable Median Interquartile range  Median Interquartile range  Median Interquartile range  Median Interquartile range 
Age group 
          <60 5.5 0-25.5 
 
3 0-31.5 
 
6 0-19 
 
25.5 8-81 
60-69 8 1-26 
 
2 0-6 
 
2 0-12.5 
 
20.5 7-63 
>60 5 0-15.5 
 
1 0-15 
 
7 0-24 
 
22 7-54 
Sex 
          Female 5 0-21 
 
1.5 0-13.5 
 
4 0-15 
 
25 7-60.5 
Male 8 1-26.5 
 
2 0-15 
 
6 0-17 
 
24 8-66 
Ethnicity 
White British 6 0-22 
 
2 0-16 
 
4 0-15 
 
24 7-66 
Other 6 0-23.5 
 
0 0-7 
 
5 0-25 
 
20 7-60 
Housebound 
No 7 0-29 1 0-11 6 0-17 25 7-77 
Yes 3 0-8 
 
4 0-24 
 
4.5 0-11 
 
15 6-44 
Problems in communication 
No 7 0-26 2 0-16 4 0-16 25 7-74.5 
Yes 2 0-29 
 
0 0-5.5 
 
7 0-16 
 
21.5 7-60 
Symptoms                       
Headache 9 2-45   6 0-30   2 0-11   30 11-86 
     Headache only 10 4-101   17.5 5-64   2 0-10   61 20-197 
     Headache plus 6 2-18.5   4 0-24   2 0-15   23 7-60 
Behavioural/cognitive  14 3-62   4 0-16   9 0-19   39 13-90 
     Confusion 16.5 7-31   1.5 0-6   2.5 0-16   18.5 4.5-41 
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     Memory 14 2-62   5 0-21   11 2-21   62 35-95 
Focal neurology 5 0-14   0 0-7.5   9 0-24   21 7-61 
Fits, faints or falls 3.5 0-30   0 0-5   0 0-11   10 0-42 
Non-specific neurological 12.5 0-28   15 0-35   8 1-17   50 43-65 
Other/non-specific 3 0-22   3 0-80   4.5 0-7   16 7-66 
Investigation before referral 
No 5 0-18 0 0-4 3.5 0-15 14.5 5-50 
Yes 13 1-31 11 4-43 7 0-19 55.5 30-110 
Type of referral 
Emergency 4.5 0-18 0 0-6 0 0-3 14 6-39 
Not referred by practice 10 0-22 2 0-6.5 0 0-7 7 0-23 
2 week/private 13.5 5-30.5 4 0-16 8 5-11.5 39 15-78 
Routine 6 0-33 7 0-80 24.5 12.5-53.5 81 50-141 
Which specialist to be referred 
A&E
†1
 5 0-10  0 0-4  0 0-7  11 7-25 
Neurosur/Neurol
†2
 8.5 1-26  5 0-33  8 1-19  43.5 10-83 
Med/stroke/Opth/Paeds/Miscl
†3
 5 0-29  1 0-11  3 0-19  27 8-82 
*1
 patient with missing values (n=28) are excluded, 
*2
 patient with missing values (n=45) are excluded, 
*3
 patient with missing values (n=49) are excluded, 
*4
 patient with missing values (n=46) are excluded 
†1
Accident & Emergency, 
†2 
Neurosurgery & Neurology, 
†3
 Medicine & Geriatrics, stroke,
 
Ophthalmology, Paediatrics & Miscellaneous.   
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Table 3. Odds ratios and 95% confidence intervals for slowest quartile time along patient pathway to diagnosis  
Time to diagnosis 
Slowest quartile for first symptom 
to first attend the GPs 
Slowest quartile for first attend the 
GPs to Referral 
Slowest quartile for referral to see 
the specialist 
Slowest quartile for first symptoms 
to see the specialist 
  n/total 
Odds 
ratio 95%CI   n/total 
Odds 
ratio 95%CI   n/total 
Odds 
ratio 95%CI   n/total 
Odds 
ratio 95%CI 
Age group
*1
 
              <60 21/84 1.01 0.43-2.35  24/84 2.53 0.98-6.52  20/84 1.74 0.62-4.86 
 
25/84 1.38 0.60-3.19 
60-69 14/56 1.00 (reference)  9/56 1.00 (reference)  9/56 1.00 (reference) 14/56 1.00 (reference) 
>60 19/86 0.83 0.36-1.91  20/86 1.72 0.66-4.51  26/86 2.46 0.99-6.17 19/86 0.88 0.27-2.12 
             
Sex
*2
            
Female 24/105 1.00 (reference)  25/105 1.00 (reference)  25/105 1.00 (reference) 25/105 1.00 (reference) 
Male 30/121 1.08 0.54-2.14  28/121 0.96 0.49-1.89  30/121 1.18 0.59-2.35 33/121 1.13 0.60-2.10 
           
Ethnicity
*3
            
    White British 48/195 1.00 (reference)  48/195 1.00 (reference)  46/195 1.00 (reference) 
 
52/195 1.00 (reference) 
Other 7/31 0.92 0.34-2.51  5/31 0.43 0.13-1.40  9/31 1.23 0.47-3.17 
 
6/31 0.61 0.21-1.78 
           
Housebound
*4
            
No 54/196 1.00 (reference)  42/196 1.00 (reference)  48/196 1.00 (reference) 54/196 1.00 (reference) 
Yes 1/31 0.10 0.01-0.77  11/31 2.45 0.90-6.69  7/31 0.61 0.18-2.03 4/31 0.42 0.11-1.60 
              
Problems in communication
*4
               
No 48/196 1.00 (reference)  49/196 1.00 (reference)  48/196 1.00 (reference) 
 
52/196 1.00 (reference) 
Yes 7/30 0.93 0.32-2.72  4/30 0.44 0.12-1.65  7/30 0.80 0.27-2.37 
 
6/30 0.78 0.25-2.41 
 
           
 
   
Symptoms
*4
                 
Headache 13/47 1.13 0.39-3.22  15/47 6.47 1.22-34.3  10/47 1.18 0.39-3.61   15/47 2.33 0.80-6.80 
    Headache only 6/16 1.96 0.54-7.05  8/16 11.8 1.88-73.9  3/16 0.92 0.18-4.55   7/16 4.11 1.10-15.5 
    Headache_plus 7/31 0.81 0.23-2.80  8/31 4.54 0.78-26.5  7/31 1.34 0.39-4.54   8/31 1.68 0.50-5.60 
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Behavioural/cognitive  10/28 1.64 0.55-4.85  7/28 5.41 0.98-29.8  8/28 1.59 0.47-5.37  9/28 2.62 0.77-8.90 
    Confusion 3/14 0.97 0.22-4.28  1/14 1.55 0.11-21.3  3/14 1.06 0.17-6.53  2/14 1.13 0.20-6.59 
    Memory 6/14 2.55 0.67-9.68  6/14 10.9 1.79-66.1  5/14 2.15 0.52-8.84  7/14 4.82 1.15-20.1 
Focal neurology  14/75 0.70 0.26-1.87  14/75 3.37 0.69-16.52  22/75 1.61 0.60-4.31  18/75 1.79 0.62-5.17 
Fits, faints or falls 11/47 1.00 (reference)   3/47 1.00 (reference)   9/47 1.00 (reference)   7/47 1.00 (reference) 
Non-specific neurological 3/11 0.96 0.16-5.79  5/11 11.9 1.82-77.8  3/11 1.73 0.36-8.45  2/11 1.29 1.96-8.51 
Other/non-specific 5/18 1.15 0.27-4.88  7/18 8.23 1.03-66.0  3/18 0.71 0.14-3.60  7/18 3.35 0.89-12.65 
                Investigation before referral
*4
 
No 31/153 1.00 (reference)  20/153 1.00 (reference)  34/153 1.00 (reference)  24/153 1.00 (reference) 
Yes 24/73 2.02 1.01-4.03  32/73 5.53 2.62-11.67  21/73 1.33 0.68-2.60  34/73 4.81 2.36-9.79 
               
Type of referral
*4
                
Emergency 20/98 1.00 (reference)  16/98 1.00 (reference)  11/98 1.00 (reference)  17/98 1.00 (reference) 
Not referred by practice 7/38 0.79 0.24-2.55  5/38 0.70 0.18-2.73  6/38 1.57 0.34-7.22  4/38 0.57 0.17-1.89 
2 week/private 13/46 1.56 0.67-3.61  14/46 2.26 0.89-2.73  10/46 2.17 0.74-6.39  13/46 1.78 0.72-4.44 
Routine 15/44 2.08 0.86-4.99  18/44 3.67 1.53-8.85  28/44 14.5 5.13-40.8  24/44 5.72 2.26-14.5 
               
Which specialist to be referred
*4
                
A&E
†1
 3/24 1.00 (reference)  3/24 1.00 (reference)  2/24 1.00 (reference)  1/24 1.00 (reference) 
Neurosur/Neurol
†2
 20/84 2.81 0.53-15.0  28/84 4.35 0.68-27.8  22/84 5.60 0.69-45.6  23/84 7.42 0.83-66.2 
Med/stroke/Opth/Paeds/Miscl
†3
 33/118 3.82 0.73-19.9  21/118 1.97 0.32-11.9  31/118 5.52 0.69-44.1  34/118 9.45 1.03-87.1 
ᵻ
Long time to diagnosis defined as worst quartile of time to diagnosis period 
*1
Adjusted for sex and ethnicity; 
*2
Adjusted for age group and ethnicity; 
*3
Adjusted for age group and sex; 
*4
Adjusted for age group, sex, and ethnicity 
†1
Accident & Emergency, 
†2 
Neurosurgery & Neurology, 
†3
 Medicine & Geriatrics, stroke,
 
Ophthalmology, Paediatrics & Miscellaneous.   
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Table 4: The association between symptom domain and frequent attendance, GP perception of need for rapid access investigations and avoidable delay 
Attend 3+ times 
Rapid access 
investigations Avoidable delays 
n/total Odds ratio 95% CI n/total Odds ratio 95% CI n/total Odds ratio 95% CI 
Symptoms* 
            Headache 21/44 4.50 1.39-14.6 18/45 7.27 1.83-28.9 13/46 2.63 0.81-8.59 
    Headache only 11/16 7.92 1.80-34.8 11/15 42.77 7.01-261.2 5/16 3.64 0.83-15.9 
    Headache plus 
 
10/28 3.27 0.91-11.8 
 
7/30 2.88 0.62-13.4 
 
8/30 2.17 0.59-8.04 
Behavioural/cognitive  11/25 4.32 1.18-15.8 5/25 2.02 0.40-10.2 3/27 1.00 0.21-4.67 
    Confusion 4/12 2.99 0.61-14.8 0/12 1.00 2/14 1.38 0.22-8.47 
    Memory 
 
7/13 6.09 1.30-28.6 
 
5/13 4.13 0.74-23.1 
 
1/13 0.64 0.07-6.29 
Focal neurology  22/64 2.71 0.88-8.34 17/68 4.30 1.14-14.1 16/74 2.13 0.70-6.45 
Fits, faints or falls 
 
7/36 1.00 (reference) 
 
4/40 1.00 (reference) 
 
6/46 1.00 (reference) 
Non-specific neurological 5/11 4.12 0.79-21.4 
 
1/11 1.27 0.11-14.1 
 
3/11 3.59 0.65-19.66 
Other/non-specific 10/15 10.17 2.12-48.8 1/14 0.91 0.08-9.86 2/17 0.83 0.14-6.94 
* Odds ratios adjusted for age group, gender and 
ethnicity 
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Supplementary table 1. Symptom domains with some examples of specific symptoms 
 
1. Headache 
   1-1. Headache only Headache 
   1-2. Headache plus Headache plus any other neurological feature 
2. Behavioural / cognitive  
   2-1. Confusion Confusion 
   2-2. memory e.g. Memory Loss 
e.g. Poor concentration 
 
e.g. Cognitive decline 
 
e.g. strange behaviour 
3. Focal neurology Hemiparesis 
Ataxia 
TIA, CVA, Stroke, stroke-like symptoms 
Incoordination 
Dysphasia 
Double vision, diplopia, loss of vision 
Slurred speech 
Vertigo 
 
Sudden onset deafness 
 
6th nerve palsy 
 
Weakness and numbness 
Poor co-ordination 
Squint 
4. Fits, faints or falls Seizure 
Collapse 
Fit 
Funny turns 
Fainting 
 
Falls 
 
Convulsion 
 
Strange sensation in stomach and strange taste sensation 
5. Non-specific neurological Poor balance 
Dizziness 
Gait abnormality 
6. Other/non-specific Vomiting 
Nausea 
Breast Lump 
Lethargy 
 
Sweating 
 
General malaise 
 
UTI 
Tinea leg 
Cyst 
  Not known 
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Supplementary table 2. Odds ratios and 95 confidence intervals for long time to diagnosis vs. short time to diagnosis without imputation 
 
Time to diagnosis 
 
Slowest quartile for first 
symptom to first attend the 
GPs 
 
Slowest quartile for first 
attend the GPs to Referral 
 
Slowest quartile for referral 
to see the specialist 
 
Slowest quartile for first 
symptoms to see the 
specialist 
  n/total 
Odds 
ratio 95%CI   n/total 
Odds 
ratio 95%CI   n/total 
Odds 
ratio 95%CI   n/total 
Odds 
ratio 95%CI 
Age group
*1
 
              <60 17/68 0.87 0.35-2.15 
 
21/64 3.99 1.33-11.9 
 
17/63 3.86 1.17-12.7 
 
22/74 1.47 0.61-3.58 
60-69 12/46 1.00 
  
7/46 1.00 
  
7/48 1.00 
  
11/48 1.00 
 >60 14/64 0.69 0.26-1.82 16/63 2.78 0.90-8.56 21/65 5.05 1.54-16.6 15/73 0.88 0.34-2.28 
Sex
*2
 
              Female 19/81 1.00 
  
20/84 1.00 
  
21/86 1.00 
  
22/92 1.00 
 
Male 
26/10
0 1.19 0.56-2.52 
 
24/93 1.16 0.55-2.46 
 
24/94 1.57 0.74-3.32 
 
27/106 1.24 0.61-2.51 
Ethnicity
*3
 
              
White british 
34/14
2 1.00 
  
36/139 1.00 
  
33/14
1 1.00 
  
40/158 1.00 
 Other 6/24 1.14 0.41-3.17 
 
4/25 0.42 0.13-1.35 
 
7/25 1.08 0.40-2.90 
 
5/25 0.69 0.24-2.00 
Housebound
*4
 
No 
42/15
3 1.00 
  
35/153 1.00 
  
40/15
5 1.00 
  
44/165 1.00 
 Yes 1/19 0.16 0.20-1.32 
 
7/19 2.41 0.81-7.14 
 
4/20 0.37 0.10-1.45 
 
3/23 0.48 0.13-1.80 
Problems in communication
*4
 
No 
40/15
4 1.00 
  
39/151 1.00 
  
38/15
3 1.00 
  
44/168 1.00 
 Yes 5/19 1.3 0.42-4.03 
 
3/20 0.55 0.14-2.09 
 
5/21 0.75 0.23-2.37 
 
5/22 1.03 0.35-3.08 
Symptoms
*4
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33
34
35
36
37
38
39
40
41
42
43
44
45
46
47
48
49
50
51
52
53
54
55
56
57
58
59
60
For Peer Review
Headache 12/43 0.83 0.25-2.73 14/41 12.48 1.46-106.6 8/41 1.09 0.29-4.10 14/45 1.79 0.57-1.79 
     Headache only 6/15 1.43 0.32-6.30 7/14 19.02 1.87-193.6 2/14 0.76 0.12-4.90 7/15 3.12 0.73-13.2 
     Headache plus 6/28 0.58 0.14-2.39 7/27 9.43 1.03-86.7 6/27 1.28 0.31-5.30 7/30 1.32 0.36-4.82 
Behavioural/cognitive  9/23 2.26 0.66-7.80 7/23 9.30 0.98-87.8 7/23 1.50 0.37-6.11 8/25 2.66 0.77-9.21 
     Confusion 3/10 1.44 0.26-8.04 
 
1/10 3.70 0.20-69.9 
 
2/10 1.61 0.23-11.3 
 
2/12 1.25 0.21-7.60 
     Memory 6/13 2.99 0.71-12.7 
 
6/13 13.84 1.33-143.9 
 
5/13 1.44 0.29-7.08 
 
6/13 4.36 1.03-18.4 
Focal neurology  10/61 0.64 0.21-2.00 
 
12/64 6.04 0.72-50.7 
 
20/65 1.63 0.50-5.29 
 
15/65 1.59 0.53-4.71 
Fits, faints or falls 9/34 1.00 (reference) 
 
2/29 1.00 (reference) 
 
6/31 1.00 (reference) 
 
6/41 1.00 (reference) 
Cranial nerve 2/8 1.35 0.21-8.71 5/10 20.22 1.71-239.0 3/10 2.30 0.38-14.0 2/9 1.57 0.25-9.91 
Other/non-specific 3/12 1.27 0.24-6.59 4/10 13.37 1.19-149.6 1/10 0.36 0.04-3.65 4/13 2.72 0.58-12.8 
Investigation before referral
*4
 
No 
23/11
4 1.00 
  
14/110 1.00 
  
27/11
4 1.00 
  
20/130 1.00 
 Yes 21/64 1.85 0.87-3.94 
 
30/65 6.96 3.04-15.9 
 
18/63 1.20 0.56-2.59 
 
29/62 5.14 2.46-10.8 
Type of referral
*4
 
Emergency 17/80 1.00 
  
13/82 1.00 
  
9/83 1.00 
  
14/82 1.00 
 Not referred by practice 3/15 0.98 0.24-4.02 
 
1/8 0.89 0.09-8.43 
 
1/11 1.50 0.16-14.3 
 
2/27 0.33 0.07-1.60 
2 week/private 12/40 1.66 0.65-4.27 
 
12/41 2.21 0.82-5.97 
 
7/40 2.47 0.78-7.81 
 
11/39 2.04 0.77-5.37 
Routine 10/31 2.11 0.78-5.74 15/37 3.58 1.38-9.27 22/36 15.74 5.25-47.2 17/31 6.94 2.56-18.8 
Which specialist to be referrerd
*4
 
Med/Eyes/Stroke/Miscell 2/16 1.00 
  
2/15 1.00 
  
1/16 1.00 
  
1/17 1.00 
 Neurosur/Neurol/Paeds 15/58 3.82 0.45-32.5 
 
23/59 4.56 0.90-23.2 
 
18/62 6.50 0.77-55.0 
 
19/64 6.08 0.73-50.7 
A&E 25/95 6.00 0.73-49.4 
 
19/99 1.86 0.37-9.33 
 
25/98 5.57 0.67-46.1 
 
27/95 8.18 0.99-67.7 
ᵻ
Long time to diagnosis defined as worst quartile of time to diagnosis period 
*1
Adjusted for sex and ethnicity;
 *2
Adjusted for age group and ethnicity; 
*3
Adjusted for age group and sex; 
*4
Adjusted for age group, sex, and ethnicity 
†1
Accident & Emergency, 
†2 
Neurosurgery & Neurology, 
†3
 Medicine & Geriatrics, stroke,
 
Ophthalmology, Paediatrics & Miscellaneous.   
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